A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806

Category Primary study
JournalBLOOD
Year 2015
This article has no abstract
Epistemonikos ID: 5da143bbb6ce24f3b7ae0811ae9ea0d8a327650e
First added on: Feb 19, 2025